Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
The study objectives are:
Objective 1: Assess feasibility (participation rate, retention, involvement, satisfaction) of one game-based interventions targeting HPV vaccination.
Objective 2: Conduct a pilot RCT with three conditions (Arm 1: HPV game-based intervention; Arm 2: usual care). The investigators will explore patterns of pre- to post-intervention change in theoretical mediators and vaccine intent, and explore levels of vaccine intent and uptake in 90 parent-child dyads of unvaccinated youth aged 11-14.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| HPV game group | Experimental | parent-child dyads receive HPV game intervention |
|
| Usual care | No Intervention | parent-child dyads receive usual care (no intervention) |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| vaccination game | Behavioral | A health game to promote HPV vaccination among youth |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of eligible individuals agreeing to participate | Assessed by the % of eligible individuals agreeing to participate | T0 (occurs after consenting and before assigning to different study conditions) |
| Proportion of participants who are retained through follow-up | Assessed by the % of participants who are retained through follow-up | T2 (occurs two months after completion of the intervention) |
| Percentage of participants who complete the intervention and assessments | Assessed by the % of participants who complete the intervention and assessments | T2 (occurs two months after completion of the intervention) |
| Participant satisfaction with the project | Assessed by two Likert scale questions: (1) are you satisfied with the program? (2) Will you recommend this program to others? Responses: from (1) very dissatisfied/definitely not to (5) very satisfied/definitely yes) | T2 (occurs two months after completion of the intervention) |
| Intention to vaccinate the children against HPV | Assessed by a Likert scale question: How likely will you (parent) vaccinate your child against HPV? Responses: (0) no; (1) maybe; (2) yes | T0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention) |
| Measure | Description | Time Frame |
|---|---|---|
| Children receives the first dose of HPV vaccine | Assessed by one binary question regarding whether or not the child has received the first dose of HPV vaccine. Responses: yes, no | T2 (occurs two months after completion of the intervention) |
Not provided
Inclusion Criteria:
Exclusion Criteria: Individuals who do not meet inclusion criteria or refuse to provide consent/assent.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| ANGELA CHEN, PhD | Contact | (517) 884-4645 | VaccineHealthGame@msu.edu | |
| Nouran Ghonaim, BS | Contact | (517) 884-4645 | VaccineHealthGame@msu.edu |
| Name | Affiliation | Role |
|---|---|---|
| ANGELA C CHEN, PhD | Michigan State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Community | Recruiting | Chandler | Arizona | 85224 | United States |
De-identified, non-sensitive data will be deposited in Dryad no later than the date of publication.
Not provided
Start: no later than the date of publication End: remain publicly available for 3 years following publication
All users will have open access to the data without restriction, consistent with Dryad's open-access model. Data can be accessed directly through Dryad's website using the assigned DOI, ensuring discoverability and persistent availability. No personally identifiable or sensitive information will be shared.
Not provided
Not provided
| ID | Term |
|---|---|
| D000079263 | Vaccine-Preventable Diseases |
| ID | Term |
|---|---|
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided